1,3-DI-HABA KANAMYCIN A
UNII ZXG8XXK4VX

Substance Identification & Data

This profile provides standardized clinical and technical data for 1,3-di-haba Kanamycin A, uniquely identified by the FDA Unique Ingredient Identifier (UNII) ZXG8XXK4VX.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 927821-99-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

ZXG8XXK4VX

CAS Registry Number

927821-99-6

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

1,3-DI-HABA KANAMYCIN A

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C26H50N6O15

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

HVNATBKIPCIZAA-NVZIBTGPSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

102307373

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

O([C@H]1[C@H](NC([C@H](CCN)O)=O)C[C@H](NC([C@H](CCN)O)=O)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@@H]1O)[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for 1,3-di-haba Kanamycin A. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

1,3-DI-HABA KANAMYCIN A

AMIKACIN IMPURITY B

Systematic Nomenclature

(2S,2'S)-N,N'-((1S,3R,4S,5R,6R)-4-(((2S,3R,4S,5S,6R)-4-AMINO-3,5-DIHYDROXY-6-(HYDROXYMETHYL)TETRAHYDRO-2H-PYRAN-2-YL)OXY)-6-(((2R,3R,4S,5S,6R)-6-(AMINOMETHYL)-3,4,5-TRIHYDROXYTETRAHYDRO-2H-PYRAN-2-YL)OXY)-5-HYDROXYCYCLOHEXANE-1,3-DIYL)BIS(4-AMINO-2-HYDROXYBUTANAMIDE)

SYS

4-AMINO-N-((1R,2S,5S)-5-((S)-4-AMINO-2-HYDROXYBUTANAMIDO)-2-(((2S,4S,5S)-4-AMINO-3,5-DIHYDROXY-6-(HYDROXYMETHYL)TETRAHYDRO-2H-PYRAN-2-YL)OXY)-4-(((2R,5S)-6-(AMINOMETHYL)-3,4,5-TRIHYDROXYTETRAHYDRO-2H-PYRAN-2-YL)OXY)-3-HYDROXYCYCLOHEXYL)-2-HYDROXYBUTANAMIDE

SYS

D-STREPTAMINE, O-3-AMINO-3-DEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->6)-O-(6-AMINO-6-DEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->4))-N1,N3-BIS((2S)-4-AMINO-2-HYDROXY-1-OXOBUTYL)-2-DEOXY-

SYS

O-3-AMINO-3-DEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->6)-O-(6-AMINO-6-DEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->4))-N1,N3-BIS((2S)-4-AMINO-2-HYDROXY-1-OXOBUTYL)-2-DEOXY-D-STREPTAMINE

SYS

External Clinical & Regulatory Resources

Previous UNIIZXG62C6UHD

Next UNIIZXH1IGJ511